Mabspace Biosciences (Suzhou) Co., Limited – Trademark Portfolio
Entity Type: 99
Mabspace Biosciences (Suzhou) Co., Limited holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TRANSCENTA. The owner is based in SUZHOU.
218 XINGHU STREET, BIOBAY B6-501
SUZHOU 215000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Mabspace Biosciences (Suzhou) Co., Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Mabspace Biosciences (Suzhou) Co., Limited have?
Mabspace Biosciences (Suzhou) Co., Limited has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.
What trademark classes does Mabspace Biosciences (Suzhou) Co., Limited file in?
Mabspace Biosciences (Suzhou) Co., Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Mabspace Biosciences (Suzhou) Co., Limited's most well-known trademarks?
Mabspace Biosciences (Suzhou) Co., Limited's registered trademark portfolio includes well-known marks such as TRANSCENTA. These are among 2 currently registered trademarks in the portfolio.
What is Mabspace Biosciences (Suzhou) Co., Limited's trademark registration success rate?
Mabspace Biosciences (Suzhou) Co., Limited has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.